-
Changes proposed for emergency CDs for European visitors
2 Sep 10 | 13.27 | EU
Pharmacists should be able to make emergency supplies of schedule 4 and 5 Controlled Drugs and phenobarbital to European Economic Area and Swiss nationals more >
-
PJ letters (4 September 2010) (RPSGB members only)
3 Sep 10 | 7.03 | England EU International Northern Ireland Scotland Wales
Letters published in the 4 September 2010 issue of The Pharmaceutical Journal more >
-
Pandemrix might cause narcolepsy
31 Aug 10 | 16.13 | EU
Possible links between narcolepsy and the swine influenza vaccine Pandemrix are being investigated by the European Medicines Agency
more > -
PJ letters (21/28 August 2010) (RPSGB members only)
20 Aug 10 | 7.03 | England EU International Northern Ireland Scotland Wales
Letters published in the 21/28 August 2010 issue of The Pharmaceutical Journal more >
-
Regulations for advanced therapy medicinal products to come into effect
17 Aug 10 | 10.08 | England EU Northern Ireland Scotland Wales
Regulations that require advanced therapy medicinal products (ATMPs) — gene therapies, somatic cell therapies and tissue engineered products — to have a centralised European marketing authorisation are due to come into force this week (19 August 2010) more >
-
Adverse drug reaction reports to be made available to the public
12 Aug 10 | 11.51 | EU
Future adverse drug reaction reports from the European Medicines Agency will be anonymised and made accessible by the public, PJ Online can reveal more >
-
Pfizer seasonal influenza vaccine puts under-fives at risk of febrile convulsions
9 Aug 10 | 16.13 | England EU International Northern Ireland Scotland Wales
Children under five years of age may be at risk of febrile convulsions if given the Pfizer seasonal influenza vaccine Enzira more >
-
PJ letters (7/14 August 2010) (RPSGB members only)
6 Aug 10 | 7.03 | England EU International Northern Ireland Scotland Wales
Letters published in the 7/14 August 2010 issue of The Pharmaceutical Journal more >
-
EMA suspends marketing of certain opioids
5 Aug 10 | 15.00 | England EU Northern Ireland Scotland Wales
Marketing authorisations for opioid products that use polymethacrylate-triethylcitrate controlled release systems should be suspended because of concerns about an interaction with alcohol, the European Medicines Agency has said more >
-
Topical ketoprofen products should not be available OTC, the European Medicines Agency recommends
27 Jul 10 | 14.08 | EU
Topical ketoprofen products should no longer be available over the counter, the European Medicines Agency has recommended following a review of these products more >
Hello guest, welcome to PJ online
gateway to the world of pharmacy and medicines
